✦ LIBER ✦
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
✍ Scribed by A.N. Alexander; M.K. Huelsmeyer; Ann Mitzey; R.R. Dubielzig; I.D. Kurzman; E.G. MacEwen; D.M. Vail
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 312 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.